Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Diversifying crypto portfolios reduces concentration risk and smooths performance across market cycles. A varied mix helps you weather downturns while maintaining growth opportunities.
22,783 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
A new Redfin analysis using Federal Reserve data shows Americans aged 70-plus now hold a 26% share of U.S. real estat...
A newer NEOS-led family of covered call ETFs is drawing attention for stronger NAV resilience and higher income poten...
NVIDIA announced a strategic partnership with Thinking Machines Lab, pledging 1 gigawatt of GPU power to accelerate m...
Heading into retirement in 2026? Here's your practical guide to crafting a resilient first-year withdrawal plan. Lear...
Oil prices climb as inflation concerns linger, prompting the Fed to hold rates steady for now. The impact rising fuel...
Pre-marketing for homes, dubbed coming soon listings, has moved from niche tests to a nationwide driver of housing de...
Hess Midstream signals a major shift from expansion to cash returns, projecting $850-$900 million in adjusted free ca...
Intel and AMD slid on Friday as AI competition intensifies and supply-chain tensions weigh on the sector, despite str...
Losing a beloved figure reminds us that our finances can echo values we hold dear. This article turns grief into prac...
Many retirees are surprised to learn that part of their social security benefit can be taxed. This guide explains how...
Nvidia has built an AI powerhouse, but its stock sits at a valuation that invites scrutiny. This guide breaks down wh...